|
Spectrum of activity:
|
Gram-positive
&
Gram-negative
|
|
Details of activity:
|
Active against Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Mycobacterium smegmatis, and aminoglycoside-resistant strains of Escherichia coli and Pseudomonas aeruginosa; protein synthesis inhibitor
|
|
Description:
|
Natural product from Saccharopolyspora hirsuta subsp. kobensis; shows superior activity compared to amikacin in mice infected with Staphylococcus aureus, Escherichia coli, or Klebsiella pneumoniae
|
|
Institute where first reported:
|
Tokyo Research Laboratories, Kowa Co., Ltd.
|
|
Year first mentioned:
|
1979
|
|
Development status:
|
Experimental
|